Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Rubin Lab
Explore this Website
Home
News
About Us
Research
Lab Team
Publications
Resources
Toggle Resources menu options
FISH
Profiler
Tracking Samples
Weill Cornell Medicine
Care
Discover
Teach
Home
News
About Us
Research
Lab Team
Publications
Resources
Home
Publications
Publications
Found 115 results
Author
Title
Type
Year
Filters:
Contact-us
is
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
W
Beltran H
,
Eng K
,
Mosquera JMiguel
,
Sigaras A
,
Romanel A
,
Rennert H
,
Kossai M
,
Pauli C
,
Faltas B
,
Fontugne J
et al.
. 2015.
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
.
JAMA Oncol. 1(4):466-74.
U
Rubin MA
. 2004.
Using molecular markers to predict outcome.
.
J Urol. 172(5 Pt 2):S18-21;discussionS21-2.
T
Perner S
,
Wagner PL
,
Soltermann A
,
LaFargue C
,
Tischler V
,
Weir BA
,
Weder W
,
Meyerson M
,
Giordano TJ
,
Moch H
et al.
. 2009.
TTF1 expression in non-small cell lung carcinoma: association with TTF1 gene amplification and improved survival.
.
J Pathol. 217(1):65-72.
Rubin MA
. 2015.
Toward a prostate cancer precision medicine.
.
Urol Oncol. 33(2):73-4.
Demichelis F
,
Rubin MA
. 2007.
TMPRSS2-ETS fusion prostate cancer: biological and clinical implications.
.
J Clin Pathol. 60(11):1185-6.
Park K
,
Dalton JT
,
Narayanan R
,
Barbieri CE
,
Hancock ML
,
Bostwick DG
,
Steiner MS
,
Rubin MA
. 2014.
TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.
.
J Clin Oncol. 32(3):206-11.
Demichelis F
,
Fall K
,
Perner S
,
Andrén O
,
Schmidt F
,
Setlur SR
,
Hoshida Y
,
Mosquera J-M
,
Pawitan Y
,
Lee C
et al.
. 2007.
TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort.
.
Oncogene. 26(31):4596-9.
Perner S
,
Demichelis F
,
Beroukhim R
,
Schmidt FH
,
Mosquera J-M
,
Setlur S
,
Tchinda J
,
Tomlins SA
,
Hofer MD
,
Pienta KG
et al.
. 2006.
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer.
.
Cancer Res. 66(17):8337-41.
Perner S
,
Mosquera J-M
,
Demichelis F
,
Hofer MD
,
Paris PL
,
Simko J
,
Collins C
,
Bismar TA
,
Chinnaiyan AM
,
De Marzo AM
et al.
. 2007.
TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion.
.
Am J Surg Pathol. 31(6):882-8.
Barry M
,
Perner S
,
Demichelis F
,
Rubin MA
. 2007.
TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications.
.
Urology. 70(4):630-3.
Svensson MA
,
Lafargue CJ
,
MacDonald TY
,
Pflueger D
,
Kitabayashi N
,
Santa-Cruz AM
,
Garsha KE
,
Sathyanarayana UG
,
Riley JP
,
Yun CS
et al.
. 2011.
Testing mutual exclusivity of ETS rearranged prostate cancer.
.
Lab Invest. 91(3):404-12.
Rubin MA
. 2008.
Targeted therapy of cancer: new roles for pathologists--prostate cancer.
.
Mod Pathol. 21 Suppl 2:S44-55.
Beltran H
,
Yelensky R
,
Frampton GM
,
Park K
,
Downing SR
,
MacDonald TY
,
Jarosz M
,
Lipson D
,
Tagawa ST
,
Nanus DM
et al.
. 2013.
Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity.
.
Eur Urol. 63(5):920-6.
S
Boysen G
,
Barbieri CE
,
Prandi D
,
Blattner M
,
Chae S-S
,
Dahija A
,
Nataraj S
,
Huang D
,
Marotz C
,
Xu L
et al.
. 2015.
SPOP mutation leads to genomic instability in prostate cancer.
.
Elife. 4
Blattner M
,
Liu D
,
Robinson BD
,
Huang D
,
Poliakov A
,
Gao D
,
Nataraj S
,
Deonarine LD
,
Augello MA
,
Sailer V
et al.
. 2017.
SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling.
.
Cancer Cell. 31(3):436-451.
Mu P
,
Zhang Z
,
Benelli M
,
Karthaus WR
,
Hoover E
,
Chen C-C
,
Wongvipat J
,
Ku S-Y
,
Gao D
,
Cao Z
et al.
. 2017.
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53- and RB1-deficient prostate cancer.
.
Science. 355(6320):84-88.
Demichelis F
,
Greulich H
,
Macoska JA
,
Beroukhim R
,
Sellers WR
,
Garraway L
,
Rubin MA
. 2008.
SNP panel identification assay (SPIA): a genetic-based assay for the identification of cell lines.
.
Nucleic Acids Res. 36(7):2446-56.
Rickman DS
,
Pflueger D
,
Moss B
,
VanDoren VE
,
Chen CX
,
de la Taille A
,
Kuefer R
,
Tewari AK
,
Setlur SR
,
Demichelis F
et al.
. 2009.
SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer.
.
Cancer Res. 69(7):2734-8.
Schlick B
,
Massoner P
,
Lueking A
,
Charoentong P
,
Blattner M
,
Schaefer G
,
Marquart K
,
Theek C
,
Amersdorfer P
,
Zielinski D
et al.
. 2016.
Serum Autoantibodies in Chronic Prostate Inflammation in Prostate Cancer Patients.
.
PLoS One. 11(2):e0147739.
R
Khurana E
,
Fu Y
,
Chakravarty D
,
Demichelis F
,
Rubin MA
,
Gerstein M
. 2016.
Role of non-coding sequence variants in cancer.
.
Nat Rev Genet. 17(2):93-108.
Hofer MD
,
Kuefer R
,
Varambally S
,
Li H
,
Ma J
,
Shapiro GI
,
Gschwend JE
,
Hautmann RE
,
Sanda MG
,
Giehl K
et al.
. 2004.
The role of metastasis-associated protein 1 in prostate cancer progression.
.
Cancer Res. 64(3):825-9.
Tomlins SA
,
Rhodes DR
,
Perner S
,
Dhanasekaran SM
,
Mehra R
,
Sun X-W
,
Varambally S
,
Cao X
,
Tchinda J
,
Kuefer R
et al.
. 2005.
Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.
.
Science. 310(5748):644-8.
Q
Rubin MA
,
Zerkowski MP
,
Camp RL
,
Kuefer R
,
Hofer MD
,
Chinnaiyan AM
,
Rimm DL
. 2004.
Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements.
.
Am J Pathol. 164(3):831-40.
P
Baca SC
,
Prandi D
,
Lawrence MS
,
Mosquera JMiguel
,
Romanel A
,
Drier Y
,
Park K
,
Kitabayashi N
,
MacDonald TY
,
Ghandi M
et al.
. 2013.
Punctuated evolution of prostate cancer genomes.
.
Cell. 153(3):666-77.
Perner S
,
Hofer MD
,
Kim R
,
Shah RB
,
Li H
,
Möller P
,
Hautmann RE
,
Gschwend JE
,
Kuefer R
,
Rubin MA
. 2007.
Prostate-specific membrane antigen expression as a predictor of prostate cancer progression.
.
Hum Pathol. 38(5):696-701.
1
(current)
2
3
4
5
next ›
last »